Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions
2013 · BMC Neurology · 42 citations
https://doi.org/10.1186/1471-2377-13-72
Y
Ying Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
145
Papers
2.0K
Citations
24
h-index
59
i10-index
Ying Jiang is an academic researcher from Jiangnan University. The author has contributed to research in topics: Antifungal resistance and susceptibility & Fungal Infections and Studies & Multiple Sclerosis Research Studies. The author has an h-index of 24, co-authored 124 publications.
ORCID: 0000-0002-0040-4211Papers by this author
works2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis
2023 · Journal of Autoimmunity · 21 citations
https://doi.org/10.1016/j.jaut.2023.103148
Intraductal tubular adenomas (pyloric gland-type) of the pancreas: clinicopathologic features are similar to gastric-type intraductal papillary mucinous neoplasms and different from intraductal tubulopapillary neoplasms
2014 · Diagnostic Pathology · 16 citations
https://doi.org/10.1186/s13000-014-0172-1
Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure
2020 · BMC Infectious Diseases · 15 citations
https://doi.org/10.1186/s12879-020-05510-9
NFIL3 deficiency alleviates EAE through regulating different immune cell subsets
2021 · Journal of Advanced Research · 15 citations
https://doi.org/10.1016/j.jare.2021.10.011
The performance of rapid plasma reagin (RPR) titer in HIV-negative general paresis after neurosyphilis therapy
2018 · BMC Infectious Diseases · 13 citations
https://doi.org/10.1186/s12879-018-3062-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat